Eli Lilly and Company Customer Success Manager Salaries in Wilmington, DE
The average Eli Lilly and Company Customer Success Manager in Wilmington, DE earns an estimated $66,969 annually, which includes an estimated base salary of $55,969 with a $11,000 bonus. Eli Lilly and Company's Customer Success Manager compensation is $15,166 more than the US average for a Customer Success Manager. Customer Success Manager salaries at Eli Lilly and Company in Wilmington, DE can range from $37,000 - $105,000.
In Wilmington, DE, The Customer Support Department at Eli Lilly and Company earns $7,276 more on average than the Admin Department.
Last updated 3 months ago.
- $55,969
- avg. base
- $11,000
- avg. bonus
Customer Success Manager Salaries at Eli Lilly and Company
In Wilmington, DE, Customer Success Managers earn $3,520 more than CS Reps, and $26,322 less than Customer Service Managers.
Compensation at Eli Lilly and Company by Department
In Wilmington, DE, The Customer Support Department averages $7,276 more than the Admin Department, and $20,087 less than the Communications Department
Customer Success Manager Compensation by Gender (All Companies)
The average female Customer Success Manager at companies similar size to Eli Lilly and Company reported making $42,803, while the average male Customer Success Manager at similar sized companies reported making $51,559.
Customer Success Manager Compensation by Ethnicity (All Companies)
The average Native American Customer Success Manager at companies similar size to Eli Lilly and Company reported making $68,667, while the average African American/Black Customer Success Manager at similar sized companies reported making $38,012.
How Customer Success Managers at Eli Lilly and Company Rate Their Compensation
The majority of Customer Success Managers at Eli Lilly and Company believe they're compensated fairly. 100% of Customer Success Managers at Eli Lilly and Company say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Eli Lilly and Company
